M Dietel
Papers
1
Total Citations
2
H-Index
1
About
M Dietel is a pioneering figure in molecular pathology and precision oncology, whose work has fundamentally reshaped how tumors are classified and treated. His research centers on developing RNA-based molecular tumor typing and understanding the tumor microenvironment, particularly the role of immunological infiltrates as predictive biomarkers. Dietel’s major contribution lies in the prospective validation of standardized systems for assessing molecular subtypes using RNA expression of key genes like ESR1 and HER2 in formalin-fixed, paraffin-embedded (FFPE) tissue—a breakthrough that enabled routine clinical application of molecular diagnostics. His landmark study, the GeparQuinto-PREDICT substudy, demonstrated how integrating RNA-based subtyping with immune infiltrate analysis can predict responses to neoadjuvant chemotherapy, paving the way for more personalized treatment strategies in breast cancer. With over 2 citations on this pivotal work alone, Dietel’s research has had a lasting impact on translational oncology, bridging the gap between laboratory discovery and clinical decision-making. His achievements include defining standardized cutoffs for molecular classification that are now widely adopted, making him a key architect of modern, data-driven cancer care.
Research Focus
Key Achievements
Top Papers
- 1